In non-small cell lung cancer (NSCLC), lactylation of apolipoprotein C-II (APOC2) at the K70 site elevates extracellular lipolysis and levels of free fatty acids, contributing to tumor cell metastasis and immunotherapy resistance (116). The gene discussed is APOC2; the disease is non-small cell lung carcinoma.